Glenmark Pharmaceuticals Limited (NSE: GLENMARK) is a global research-driven pharmaceutical company that develops and markets innovative drugs for major therapeutic areas such as dermatology, respiratory, oncology, and diabetes. The company operates in over 80 countries and has manufacturing facilities in India, Switzerland, and Argentina. The company’s revenue is primarily generated through the sale of branded formulations, APIs, and generics. Glenmark has a wide customer base, which includes leading pharmaceutical companies, healthcare providers, and distributors.
For the quarter ended December 31, 2022, Glenmark Pharmaceuticals reported a consolidated revenue of ₹2,161.47 crore, representing a YoY growth of 6%. The company’s net profit for the quarter was ₹430.5 crore, representing a YoY decline of 21% from ₹548.51 Crore. The company’s India business reported a revenue of ₹1,074.5 crore for the quarter, representing a YoY growth of 6.7%. The company’s North America business reported a revenue of ₹837.3 crore for the quarter, representing a year on year growth of 10.6%.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,